Chip checks blood to see if cancer treatment is working by fourth week
Researchers have developed a chip that analyzes a patient’s blood for cells shed by a lung cancer tumor, enabling treating physicians to determine whether lung cancer treatment is working by as early as the fourth week. The information provided by the chip would allow treatment to be adapted to meet patient’s needs and improve outcomes.
Tags: Lung cancer, Treatment, Biomarkers, University of Michigan
Comentarios
Publicar un comentario